Aimmune Therapeutics, Inc. SEC Filings

Filed On	Filing
16 Feb 2021	SC 13G/A
23 Oct 2020	15-12B
19 Oct 2020	8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
15 Oct 2020	Form 4: Societe des Produits Nestle S.a., 10% owner Bought 54,117,287 shares ($1.87B)
14 Oct 2020	EFFECT
14 Oct 2020	EFFECT
14 Oct 2020	Form 4: Oxtoby Andrew, Chief Commercial Officer Disposed of 6,345 shares (Tender Offer) ($219K) · Returned 20,250 shares to the issuer ($699K) · Disposed of 217,500 Stock Option (right to buy) (Disposition to Issuer) ($2.61M)
14 Oct 2020	Form 4: Sheehy Douglas T., See Remarks Disposed of 47,450 shares (Tender Offer) ($1.64M) · Returned 36,875 shares to the issuer ($1.27M) · Disposed of 307,361 Stock Option (right to buy) (Disposition to Issuer) ($3.05M)
14 Oct 2020	Form 4: Dallas Jayson Donald Alexander, Director Disposed of 30,422 shares (Tender Offer) ($1.05M) · Returned 89,250 shares to the issuer ($3.08M) · Disposed of 760,000 Stock Option (right to buy) (Disposition to Issuer) ($5.74M)
14 Oct 2020	Form 4: Mcdade Mark, Director Disposed of 26,852 shares (Tender Offer) ($926K) · Returned 7,840 shares to the issuer ($270K) · Disposed of 176,427 Stock Option (right to buy) (Disposition to Issuer) ($4.41M)
14 Oct 2020	Form 4: Behar Gregory, Director Disposed of 10,192 shares (Other Transaction) · Returned 7,840 shares to the issuer ($270K) · Disposed of 91,340 Stock Option (right to buy) (Disposition to Issuer) ($1.11M)
14 Oct 2020	Form 4: Haumann Brett K, Director Disposed of 6,250 shares (Tender Offer) ($216K) · Returned 13,313 shares to the issuer ($459K) · Disposed of 25,453 Stock Option (right to buy) (Disposition to Issuer) ($443K)
14 Oct 2020	Form 4: Seltzer Stacey Denenberg, Director Disposed of 10,221 shares (Tender Offer) ($353K) · Returned 7,840 shares to the issuer ($270K) · Disposed of 124,006 Stock Option (right to buy) (Disposition to Issuer) ($2.59M)
14 Oct 2020	Form 4: Bjerkholt Eric, Chief Financial Officer Disposed of 27,805 shares (Tender Offer) ($959K) · Returned 23,905 shares to the issuer ($825K) · Disposed of 456,050 Stock Option (right to buy) (Disposition to Issuer) ($5.46M)
14 Oct 2020	Form 4: Iwicki Mark T, Director Disposed of 39,567 shares (Tender Offer) ($1.37M) · Returned 7,840 shares to the issuer ($270K) · Disposed of 211,374 Stock Option (right to buy) (Disposition to Issuer) ($5.22M)
14 Oct 2020	Form 4: Enright Patrick G, Director Disposed of 162,258 shares (Tender Offer) ($5.6M) · Returned 7,840 shares to the issuer ($270K) · Disposed of 189,855 Stock Option (right to buy) (Disposition to Issuer) ($4.85M)
14 Oct 2020	Form 4: Adelman Daniel C Md, Chief Medical Officer Disposed of 41,464 shares (Tender Offer) ($1.43M) · Returned 22,343 shares to the issuer ($771K) · Disposed of 385,068 Stock Option (right to buy) (Disposition to Issuer) ($5.51M)
14 Oct 2020	Form 4: Falberg Kathryn E, Director Disposed of 135,086 shares (Tender Offer) ($4.66M) · Returned 7,840 shares to the issuer ($270K) · Disposed of 71,585 Stock Option (right to buy) (Disposition to Issuer) ($1.11M)
13 Oct 2020	S-8 POS
13 Oct 2020	S-8 POS

Comments